Cellbios Healthcare & Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
- Paid Up Capital ₹ 1.20 Cr
- Company Age 16 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.95 M
- Satisfied Charges ₹ 2.00 M
- Revenue Growth 45.77%
- Profit Growth -158.38%
- Ebitda 25.82%
- Net Worth -17.74%
- Total Assets 2.52%
About Cellbios Healthcare & Lifesciences
Cellbios Healthcare & Lifesciences Private Limited (CHLPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 10 October 2008 and has a history of 16 years and four months. Its registered office is in Kanchipuram, Tamil Nadu, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 1.20 Cr.
The company currently has active open charges totaling ₹4.95 M. The company has closed loans amounting to ₹2.00 M, as per Ministry of Corporate Affairs (MCA) records.
Srikumar Kasthuri, Kalai Srinivasa, and Kasthuri Saravanan serve as directors at the Company.
Company Details
- Location
Kanchipuram, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85190TN2008PTC069513
- Company No.
069513
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Oct 2008
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
What products or services does Cellbios Healthcare & Lifesciences Private Limited offer?
Cellbios Healthcare & Lifesciences Private Limited offers a wide range of products and services, including Surgical & ICU Equipments, Ventilator Parts & Consumables, Insecticides and Pesticides, Acaricide, Infusion Syringes & Supplies, Medical Tubes, Surgical & Medical Consumables, Surgical Disposables, Scalpels, Needles & Scissors, Surgical Needles.
Who are the key members and board of directors at Cellbios Healthcare & Lifesciences?
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Srikumar Kasthuri ![]() | Director | 10-Oct-2008 | Current |
Kalai Srinivasa ![]() | Director | 04-May-2012 | Current |
Kasthuri Saravanan ![]() | Director | 01-Sep-2022 | Current |
Financial Performance of Cellbios Healthcare & Lifesciences.
Cellbios Healthcare & Lifesciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 45.77% increase. The company also saw a substantial fall in profitability, with a 158.38% decrease in profit. The company's net worth observed a substantial decline by a decrease of 17.74%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Cellbios Healthcare & Lifesciences?
In 2022, Cellbios Healthcare & Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Charges (Loans)
₹0.50 Cr
₹0.20 Cr
Charges Breakdown by Lending Institutions
- Indian Bank : 0.50 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
18 Mar 2020 | Indian Bank | ₹4.95 M | Open |
27 May 2015 | Indian Bank | ₹2.00 M | Satisfied |
How Many Employees Work at Cellbios Healthcare & Lifesciences?
Cellbios Healthcare & Lifesciences has a workforce of 58 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Cellbios Healthcare & Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cellbios Healthcare & Lifesciences's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.